 | • レポートコード：MRC2303E078 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、252ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：実験機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に6,183.53百万ドルであった世界のアブレーション装置市場規模が、2022年に6,903.30百万ドルに達し、2027年には12,136.69百万ドルまで年平均11.89%で成長すると予測しています。当調査レポートでは、アブレーション装置の世界市場について総合的に調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析（凍結アブレーション装置、電気アブレーション装置、熱水/ハイドロメカニカルアブレーション装置、レーザー/ライトアブレーション装置、その他）、機能別分析（自動、従来型）、技術別分析（凍結アブレーション装置、レーザー/光アブレーション、高周波デバイス、超音波装置）、用途別分析（がん治療、心血管系疾患治療、美容整形/美容外科、婦人科治療、その他）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況などの項目を掲載しています。なお、当書に掲載されている企業情報には、Abbott Laboratories、Alcon Vision LLC、AngioDynamics, Inc.、Arthrex, Inc、Atricure, Inc.、Bausch & Lomb Incorporated、Biotronik SE & Co. KG、Boston Scientific Corporation、Conmed Corporation、Cynosure, LLC、Elekta AB、Ethicon, Inc. (Johnson & Johnson)、IceCure Medical Ltd.、Inmode Group、Lumenis Be Ltd.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のアブレーション装置市場規模：種類別 - 凍結アブレーション装置の市場規模 - 電気アブレーション装置の市場規模 - 熱水/ハイドロメカニカルアブレーション装置の市場規模 - レーザー/ライトアブレーション装置の市場規模 - その他種類の市場規模 ・世界のアブレーション装置市場規模：機能別 - 自動アブレーション装置の市場規模 - 従来型アブレーション装置の市場規模 ・世界のアブレーション装置市場規模：技術別 - 凍結アブレーション装置の市場規模 - レーザー/光アブレーションの市場規模 - 高周波デバイスの市場規模 - 超音波装置の市場規模 ・世界のアブレーション装置市場規模：用途別 - がん治療における市場規模 - 心血管系疾患治療における市場規模 - 美容整形/美容外科における市場規模 - 婦人科治療における市場規模 - その他用途における市場規模 ・世界のアブレーション装置市場規模：地域別 - 南北アメリカのアブレーション装置市場規模 アメリカのアブレーション装置市場規模 カナダのアブレーション装置市場規模 ブラジルのアブレーション装置市場規模 ... - アジア太平洋のアブレーション装置市場規模 日本のアブレーション装置市場規模 中国のアブレーション装置市場規模 インドのアブレーション装置市場規模 韓国のアブレーション装置市場規模 台湾のアブレーション装置市場規模 ... - ヨーロッパ/中東/アフリカのアブレーション装置市場規模 イギリスのアブレーション装置市場規模 ドイツのアブレーション装置市場規模 インドのアブレーション装置市場規模 フランスのアブレーション装置市場規模 ロシアのアブレーション装置市場規模 ... - その他地域のアブレーション装置市場規模 ・競争状況 ・企業情報 |
The Global Ablation Devices Market size was estimated at USD 6,183.53 million in 2021 and expected to reach USD 6,903.30 million in 2022, and is projected to grow at a CAGR 11.89% to reach USD 12,136.69 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Ablation Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Cryoablation Devices, Electrical Ablators, Hydrothermal/Hydromechanical Ablators, Laser/Light Ablators, Microwave Ablators, Radiofrequency Ablators, and Ultrasound Ablators.
Based on Function, the market was studied across Automated and Conventional.
Based on Technology, the market was studied across Cryoablation Devices, Laser/Light Ablation, Radiofrequency Devices, and Ultrasound Devices.
Based on Application, the market was studied across Cancer Treatment, Cardiovascular Disease Treatment, Cosmetic/ Aesthetic Surgery, Gynecological Treatment, Ophthalmologic Treatment, Orthopedic Treatment, Pain Management, and Urological Treatment.
Based on End-use, the market was studied across Ambulatory Surgical Centers and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ablation Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ablation Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ablation Devices Market, including Abbott Laboratories, Alcon Vision LLC, AngioDynamics, Inc., Arthrex, Inc, Atricure, Inc., Bausch & Lomb Incorporated, Biotronik SE & Co. KG, Boston Scientific Corporation, Conmed Corporation, Cynosure, LLC, Elekta AB, Ethicon, Inc. (Johnson & Johnson), IceCure Medical Ltd., Inmode Group, Lumenis Be Ltd., Medtronic PLC, Merit Medical Systems, Inc., Olympus Corporation, Smith & Nephew PLC, Stryker Corporation, and Varian Medical Systems, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Ablation Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ablation Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ablation Devices Market?
4. What is the competitive strategic window for opportunities in the Global Ablation Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Ablation Devices Market?
6. What is the market share of the leading vendors in the Global Ablation Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Ablation Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of sports injuries and road accidents
5.1.1.2. Preference for minimally invasive procedures during surgeries
5.1.1.3. Prevalence of atrial fibrillation and other cardiac conditions
5.1.2. Restraints
5.1.2.1. Concerns regarding availability of substitutes
5.1.3. Opportunities
5.1.3.1. Development of new ablation tools, such as CF-sensing catheters or novel balloon-devices
5.1.3.2. Proliferation of radiofrequency ablation devices
5.1.4. Challenges
5.1.4.1. Product recalls and adverse effects from ablation devices
5.2. Cumulative Impact of COVID-19
6. Ablation Devices Market, by Type
6.1. Introduction
6.2. Cryoablation Devices
6.3. Electrical Ablators
6.4. Hydrothermal/Hydromechanical Ablators
6.5. Laser/Light Ablators
6.6. Microwave Ablators
6.7. Radiofrequency Ablators
6.8. Ultrasound Ablators
7. Ablation Devices Market, by Function
7.1. Introduction
7.2. Automated
7.3. Conventional
8. Ablation Devices Market, by Technology
8.1. Introduction
8.2. Cryoablation Devices
8.3. Laser/Light Ablation
8.4. Radiofrequency Devices
8.5. Ultrasound Devices
9. Ablation Devices Market, by Application
9.1. Introduction
9.2. Cancer Treatment
9.3. Cardiovascular Disease Treatment
9.4. Cosmetic/ Aesthetic Surgery
9.5. Gynecological Treatment
9.6. Ophthalmologic Treatment
9.7. Orthopedic Treatment
9.8. Pain Management
9.9. Urological Treatment
10. Ablation Devices Market, by End-use
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
11. Americas Ablation Devices Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Ablation Devices Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Ablation Devices Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Alcon Vision LLC
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. AngioDynamics, Inc.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Arthrex, Inc
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Atricure, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Bausch & Lomb Incorporated
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Biotronik SE & Co. KG
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Boston Scientific Corporation
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Conmed Corporation
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Cynosure, LLC
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Elekta AB
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Ethicon, Inc. (Johnson & Johnson)
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. IceCure Medical Ltd.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Inmode Group
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Lumenis Be Ltd.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Medtronic PLC
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Merit Medical Systems, Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Olympus Corporation
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Smith & Nephew PLC
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Stryker Corporation
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Varian Medical Systems, Inc.
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing